Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.9600 (2.52%) ($9.9600 - $9.9600) on Mon. Feb. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.5% (three month average) | RSI | 64 | Latest Price | $9.9600(2.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(69%) IBB(56%) IWC(51%) IWO(47%) IWM(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.25% in a week (0% probabilities). VIXM(-15%) SMH(-10%) IGOV(-10%) UUP(-6%) TBT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.25% (StdDev 4.5%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.24(-2.73%) | 10 Day Moving Average | $10.52(-5.32%) | 20 Day Moving Average | $9.65(3.21%) | To recent high | -23.6% | To recent low | 27.5% | Market Cap | $619m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |